Vanguard Group’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
|
|||||
|
2023
Q2 | $433M | Sell |
|
|||||
|
2023
Q1 | $372M | Buy |
|
|||||
|
2022
Q4 | $380M | Buy |
|
|||||
|
2022
Q3 | $464M | Buy |
|
|||||
|
2022
Q2 | $693M | Sell |
|
|||||
|
2022
Q1 | $787M | Buy |
|
|||||
|
2021
Q4 | $995M | Buy |
|
|||||
|
2021
Q3 | $844M | Sell |
|
|||||
|
2021
Q2 | $869M | Buy |
|
|||||
|
2021
Q1 | $600M | Buy |
|
|||||
|
2020
Q4 | $463M | Sell |
|
|||||
|
2020
Q3 | $449M | Buy |
|
|||||
|
2020
Q2 | $464M | Sell |
|
|||||
|
2020
Q1 | $324M | Buy |
|
|||||
|
2019
Q4 | $479M | Buy |
|
|||||
|
2019
Q3 | $422M | Buy |
|
|||||
|
2019
Q2 | $391M | Buy |
|
|||||
|
2019
Q1 | $374M | Buy |
|
|||||
|
2018
Q4 | $280M | Buy |
|
|||||
|
2018
Q3 | $356M | Buy |
|
|||||
|
2018
Q2 | $295M | Buy |
|
|||||
|
2018
Q1 | $223M | Buy |
|
|||||
|
2017
Q4 | $271M | Sell |
|
|||||
|
2017
Q3 | $408M | Buy |
|
|||||
|
2017
Q2 | $362M | Buy |
|
|||||
|
2017
Q1 | $277M | Buy |
|
|||||
|
2016
Q4 | $298M | Buy |
|
|||||
|
2016
Q3 | $249M | Buy |
|
|||||
|
2016
Q2 | $180M | Buy |
|
|||||
|
2016
Q1 | $150M | Buy |
|
|||||
|
2015
Q4 | $148M | Buy |
|
|||||
|
2015
Q3 | $96.4M | Buy |
|
|||||
|
2015
Q2 | $56.5M | Buy |
|
|||||
|
2015
Q1 | $23.3M | Buy |
|
|||||
|
2014
Q4 | $14.8M | Buy |
|